Andrew Saunders
Chief Tech/Sci/R&D Officer en CellCentric Ltd. .
Perfil
Andrew Saunders is currently the Chief Medical Officer at CellCentric Ltd.
He previously worked as the Managing Director at Linden Oncology Ltd.
and as the Chief Medical Officer at Bioenvision, Inc. and Lytix Biopharma AS.
He also served as the Co-Chief Medical Officer at Redx Pharma Plc from 2018 to 2021.
Dr. Saunders earned a doctorate degree from Trinity College Dublin in 1989.
Cargos activos de Andrew Saunders
| Empresas | Cargo | Inicio |
|---|---|---|
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Andrew Saunders.
| Empresas | Cargo | Fin |
|---|---|---|
| REDX PHARMA PLC | Chief Tech/Sci/R&D Officer | 01/03/2021 |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 09/04/2007 |
| Linden Oncology Ltd. | Chief Executive Officer | - |
| LYTIX BIOPHARMA | Chief Tech/Sci/R&D Officer | - |
Formación de Andrew Saunders.
| Trinity College Dublin | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| REDX PHARMA PLC | Health Technology |
| Empresas privadas | 3 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Linden Oncology Ltd. |
- Bolsa de valores
- Insiders
- Andrew Saunders
